| Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group B Dubois, N Villain, GB Frisoni, GD Rabinovici, M Sabbagh, S Cappa, ... The Lancet Neurology 20 (6), 484-496, 2021 | 564 | 2021 |
| Relationships between hippocampal atrophy, white matter disruption, and gray matter hypometabolism in Alzheimer's disease N Villain, B Desgranges, F Viader, V De La Sayette, F Mézenge, ... Journal of Neuroscience 28 (24), 6174-6181, 2008 | 449 | 2008 |
| Amyloid imaging in cognitively normal individuals, at-risk populations and preclinical Alzheimer's disease G Chételat, R La Joie, N Villain, A Perrotin, V de La Sayette, F Eustache, ... NeuroImage: Clinical, 2013 | 390 | 2013 |
| Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer’s disease: a voxelwise PiB–PET longitudinal study N Villain, G Chételat, B Grassiot, P Bourgeat, G Jones, KA Ellis, D Ames, ... Brain 135 (7), 2126-2139, 2012 | 286 | 2012 |
| Sequential relationships between grey matter and white matter atrophy and brain metabolic abnormalities in early Alzheimer's disease N Villain, M Fouquet, JC Baron, F Mézenge, B Landeau, V de La Sayette, ... Brain 133 (11), 3301-3314, 2010 | 242 | 2010 |
| Accelerated cortical atrophy in cognitively normal elderly with high β-amyloid deposition G Chételat, VL Villemagne, N Villain, G Jones, KA Ellis, D Ames, ... Neurology 78 (7), 477-484, 2012 | 201 | 2012 |
| COVID‐19‐related encephalopathy: a case series with brain FDG‐positron‐emission tomography/computed tomography findings C Delorme, O Paccoud, A Kas, A Hesters, S Bombois, P Shambrook, ... European journal of neurology 27 (12), 2651-2657, 2020 | 176 | 2020 |
| Differential effect of age on hippocampal subfields assessed using a new high-resolution 3T MR sequence R La Joie, M Fouquet, F Mézenge, B Landeau, N Villain, K Mevel, ... Neuroimage 53 (2), 506-514, 2010 | 176 | 2010 |
| Retrospective observational study of brain MRI findings in patients with acute SARS-CoV-2 infection and neurologic manifestations L Chougar, N Shor, N Weiss, D Galanaud, D Leclercq, B Mathon, ... Radiology 297 (3), E313-E323, 2020 | 171* | 2020 |
| Revolution of Alzheimer precision neurology. Passageway of systems biology and neurophysiology H Hampel, N Toschi, C Babiloni, F Baldacci, KL Black, ALW Bokde, ... Journal of Alzheimer's Disease 64 (s1), S47-S105, 2018 | 146 | 2018 |
| Age effect on the default mode network, inner thoughts, and cognitive abilities K Mevel, B Landeau, M Fouquet, R La Joie, N Villain, F Mézenge, ... Neurobiology of aging 34 (4), 1292-1301, 2013 | 143 | 2013 |
| The cerebral network of COVID-19-related encephalopathy: a longitudinal voxel-based 18F-FDG-PET study A Kas, M Soret, N Pyatigoskaya, MO Habert, A Hesters, L Le Guennec, ... European journal of nuclear medicine and molecular imaging 48 (8), 2543-2557, 2021 | 141 | 2021 |
| Plasma amyloid β 40/42 ratio predicts cerebral amyloidosis in cognitively normal individuals at risk for Alzheimer's disease A Vergallo, L Mégret, S Lista, E Cavedo, H Zetterberg, K Blennow, ... Alzheimer's & Dementia 15 (6), 764-775, 2019 | 134 | 2019 |
| Functional brain imaging of trigeminal neuralgia X Moisset, N Villain, D Ducreux, A Serrie, G Cunin, D Valade, B Calvino, ... European Journal of Pain 15 (2), 124-131, 2011 | 110 | 2011 |
| Alzheimer's disease including focal presentations N Villain, B Dubois Seminars in neurology 39 (02), 213-226, 2019 | 102 | 2019 |
| Precision pharmacology for Alzheimer’s disease H Hampel, A Vergallo, LF Aguilar, N Benda, K Broich, AC Cuello, ... Pharmacological research 130, 331-365, 2018 | 97 | 2018 |
| Omics sciences for systems biology in Alzheimer’s disease: State-of-the-art of the evidence H Hampel, R Nisticò, NT Seyfried, AI Levey, E Modeste, P Lemercier, ... Ageing Research Reviews 69, 101346, 2021 | 90 | 2021 |
| The Alzheimer precision medicine initiative H Hampel, A Vergallo, G Perry, S Lista, ... Journal of Alzheimer's Disease 68 (1), 1-24, 2019 | 85 | 2019 |
| Sex differences in functional and molecular neuroimaging biomarkers of Alzheimer's disease in cognitively normal older adults with subjective memory complaints E Cavedo, PA Chiesa, M Houot, MT Ferretti, MJ Grothe, SJ Teipel, S Lista, ... Alzheimer's & Dementia 14 (9), 1204-1215, 2018 | 85 | 2018 |
| The spatiotemporal changes in dopamine, neuromelanin and iron characterizing Parkinson’s disease E Biondetti, MD Santin, R Valabrègue, G Mangone, R Gaurav, ... Brain 144 (10), 3114-3125, 2021 | 76 | 2021 |
Gael ChételatResearcher (Inserm, French institute for biomedical research)Verified email at cyceron.fr
